03 Nov Sodium glucose co-transporter-2 inhibitors and the risk of below-knee amputation: a multicenter observational study.
Posted at 13:00h
in
Yu OHY, Dell’Aniello S, Shah BR, Brunetti V, Daigle JM, Fralick M, Douros A, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ronksley PE, Filion KB, Ernst P, Lix LM, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium glucose co-transporter-2 inhibitors and the risk of below-knee amputation: a multicenter observational study. Diabetes Care. 2020 Oct;43(10):2444-2452.